nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Esomeprazole—Barrett's esophagus	0.228	0.397	CbGbCtD
Darifenacin—CYP2D6—Omeprazole—Barrett's esophagus	0.211	0.368	CbGbCtD
Darifenacin—CYP3A4—Omeprazole—Barrett's esophagus	0.134	0.234	CbGbCtD
Darifenacin—Ulcerative stomatitis—Esomeprazole—Barrett's esophagus	0.012	0.0297	CcSEcCtD
Darifenacin—Ulcerative stomatitis—Omeprazole—Barrett's esophagus	0.012	0.0297	CcSEcCtD
Darifenacin—Accidental injury—Esomeprazole—Barrett's esophagus	0.00627	0.0155	CcSEcCtD
Darifenacin—Accidental injury—Omeprazole—Barrett's esophagus	0.00627	0.0155	CcSEcCtD
Darifenacin—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.00555	0.0137	CcSEcCtD
Darifenacin—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.00555	0.0137	CcSEcCtD
Darifenacin—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00531	0.241	CbGpPWpGaD
Darifenacin—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00524	0.013	CcSEcCtD
Darifenacin—Vaginal infection—Omeprazole—Barrett's esophagus	0.00524	0.013	CcSEcCtD
Darifenacin—Dry eye—Omeprazole—Barrett's esophagus	0.00513	0.0127	CcSEcCtD
Darifenacin—Dry eye—Esomeprazole—Barrett's esophagus	0.00513	0.0127	CcSEcCtD
Darifenacin—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00502	0.0124	CcSEcCtD
Darifenacin—Bladder pain—Esomeprazole—Barrett's esophagus	0.00502	0.0124	CcSEcCtD
Darifenacin—Bladder pain—Omeprazole—Barrett's esophagus	0.00502	0.0124	CcSEcCtD
Darifenacin—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00502	0.0124	CcSEcCtD
Darifenacin—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00484	0.012	CcSEcCtD
Darifenacin—Abnormal vision—Omeprazole—Barrett's esophagus	0.00484	0.012	CcSEcCtD
Darifenacin—Injury—Omeprazole—Barrett's esophagus	0.00438	0.0108	CcSEcCtD
Darifenacin—Injury—Esomeprazole—Barrett's esophagus	0.00438	0.0108	CcSEcCtD
Darifenacin—Visual disturbance—Omeprazole—Barrett's esophagus	0.00425	0.0105	CcSEcCtD
Darifenacin—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00425	0.0105	CcSEcCtD
Darifenacin—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00425	0.193	CbGpPWpGaD
Darifenacin—Face oedema—Esomeprazole—Barrett's esophagus	0.00389	0.00962	CcSEcCtD
Darifenacin—Face oedema—Omeprazole—Barrett's esophagus	0.00389	0.00962	CcSEcCtD
Darifenacin—Dry skin—Esomeprazole—Barrett's esophagus	0.00369	0.00913	CcSEcCtD
Darifenacin—Dry skin—Omeprazole—Barrett's esophagus	0.00369	0.00913	CcSEcCtD
Darifenacin—Breast disorder—Esomeprazole—Barrett's esophagus	0.00364	0.009	CcSEcCtD
Darifenacin—Breast disorder—Omeprazole—Barrett's esophagus	0.00364	0.009	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00363	0.00897	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00363	0.00897	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00355	0.00879	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00355	0.00879	CcSEcCtD
Darifenacin—Influenza—Omeprazole—Barrett's esophagus	0.00348	0.00861	CcSEcCtD
Darifenacin—Influenza—Esomeprazole—Barrett's esophagus	0.00348	0.00861	CcSEcCtD
Darifenacin—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00321	0.00793	CcSEcCtD
Darifenacin—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00321	0.00793	CcSEcCtD
Darifenacin—Weight increased—Esomeprazole—Barrett's esophagus	0.00317	0.00784	CcSEcCtD
Darifenacin—Weight increased—Omeprazole—Barrett's esophagus	0.00317	0.00784	CcSEcCtD
Darifenacin—Infestation NOS—Omeprazole—Barrett's esophagus	0.00311	0.00768	CcSEcCtD
Darifenacin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00311	0.00768	CcSEcCtD
Darifenacin—Infestation—Esomeprazole—Barrett's esophagus	0.00311	0.00768	CcSEcCtD
Darifenacin—Infestation—Omeprazole—Barrett's esophagus	0.00311	0.00768	CcSEcCtD
Darifenacin—Stomatitis—Omeprazole—Barrett's esophagus	0.00303	0.00749	CcSEcCtD
Darifenacin—Stomatitis—Esomeprazole—Barrett's esophagus	0.00303	0.00749	CcSEcCtD
Darifenacin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00302	0.00746	CcSEcCtD
Darifenacin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00302	0.00746	CcSEcCtD
Darifenacin—Sinusitis—Omeprazole—Barrett's esophagus	0.00291	0.0072	CcSEcCtD
Darifenacin—Sinusitis—Esomeprazole—Barrett's esophagus	0.00291	0.0072	CcSEcCtD
Darifenacin—Rhinitis—Esomeprazole—Barrett's esophagus	0.00279	0.00691	CcSEcCtD
Darifenacin—Rhinitis—Omeprazole—Barrett's esophagus	0.00279	0.00691	CcSEcCtD
Darifenacin—Hallucination—Esomeprazole—Barrett's esophagus	0.00277	0.00686	CcSEcCtD
Darifenacin—Hallucination—Omeprazole—Barrett's esophagus	0.00277	0.00686	CcSEcCtD
Darifenacin—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00277	0.00684	CcSEcCtD
Darifenacin—Pharyngitis—Omeprazole—Barrett's esophagus	0.00277	0.00684	CcSEcCtD
Darifenacin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00275	0.00681	CcSEcCtD
Darifenacin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00275	0.00681	CcSEcCtD
Darifenacin—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00275	0.00679	CcSEcCtD
Darifenacin—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00275	0.00679	CcSEcCtD
Darifenacin—Urethral disorder—Omeprazole—Barrett's esophagus	0.00273	0.00676	CcSEcCtD
Darifenacin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00273	0.00676	CcSEcCtD
Darifenacin—Visual impairment—Omeprazole—Barrett's esophagus	0.00269	0.00664	CcSEcCtD
Darifenacin—Visual impairment—Esomeprazole—Barrett's esophagus	0.00269	0.00664	CcSEcCtD
Darifenacin—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00264	0.00652	CcSEcCtD
Darifenacin—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00264	0.00652	CcSEcCtD
Darifenacin—Eye disorder—Esomeprazole—Barrett's esophagus	0.00261	0.00644	CcSEcCtD
Darifenacin—Eye disorder—Omeprazole—Barrett's esophagus	0.00261	0.00644	CcSEcCtD
Darifenacin—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00251	0.00621	CcSEcCtD
Darifenacin—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00251	0.00621	CcSEcCtD
Darifenacin—Mental disorder—Esomeprazole—Barrett's esophagus	0.00244	0.00604	CcSEcCtD
Darifenacin—Mental disorder—Omeprazole—Barrett's esophagus	0.00244	0.00604	CcSEcCtD
Darifenacin—Flatulence—Esomeprazole—Barrett's esophagus	0.00239	0.00591	CcSEcCtD
Darifenacin—Flatulence—Omeprazole—Barrett's esophagus	0.00239	0.00591	CcSEcCtD
Darifenacin—Dysgeusia—Omeprazole—Barrett's esophagus	0.00238	0.00588	CcSEcCtD
Darifenacin—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00238	0.00588	CcSEcCtD
Darifenacin—Back pain—Esomeprazole—Barrett's esophagus	0.00235	0.0058	CcSEcCtD
Darifenacin—Back pain—Omeprazole—Barrett's esophagus	0.00235	0.0058	CcSEcCtD
Darifenacin—Vision blurred—Esomeprazole—Barrett's esophagus	0.00229	0.00566	CcSEcCtD
Darifenacin—Vision blurred—Omeprazole—Barrett's esophagus	0.00229	0.00566	CcSEcCtD
Darifenacin—Angioedema—Esomeprazole—Barrett's esophagus	0.00222	0.00548	CcSEcCtD
Darifenacin—Angioedema—Omeprazole—Barrett's esophagus	0.00222	0.00548	CcSEcCtD
Darifenacin—Palpitations—Esomeprazole—Barrett's esophagus	0.00214	0.0053	CcSEcCtD
Darifenacin—Palpitations—Omeprazole—Barrett's esophagus	0.00214	0.0053	CcSEcCtD
Darifenacin—Cough—Esomeprazole—Barrett's esophagus	0.00212	0.00524	CcSEcCtD
Darifenacin—Cough—Omeprazole—Barrett's esophagus	0.00212	0.00524	CcSEcCtD
Darifenacin—Hypertension—Esomeprazole—Barrett's esophagus	0.0021	0.00518	CcSEcCtD
Darifenacin—Hypertension—Omeprazole—Barrett's esophagus	0.0021	0.00518	CcSEcCtD
Darifenacin—Arthralgia—Omeprazole—Barrett's esophagus	0.00207	0.00511	CcSEcCtD
Darifenacin—Arthralgia—Esomeprazole—Barrett's esophagus	0.00207	0.00511	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00205	0.00507	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00205	0.00507	CcSEcCtD
Darifenacin—Dry mouth—Esomeprazole—Barrett's esophagus	0.00202	0.005	CcSEcCtD
Darifenacin—Dry mouth—Omeprazole—Barrett's esophagus	0.00202	0.005	CcSEcCtD
Darifenacin—Confusional state—Esomeprazole—Barrett's esophagus	0.002	0.00494	CcSEcCtD
Darifenacin—Confusional state—Omeprazole—Barrett's esophagus	0.002	0.00494	CcSEcCtD
Darifenacin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00198	0.0049	CcSEcCtD
Darifenacin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00198	0.0049	CcSEcCtD
Darifenacin—Infection—Esomeprazole—Barrett's esophagus	0.00197	0.00487	CcSEcCtD
Darifenacin—Infection—Omeprazole—Barrett's esophagus	0.00197	0.00487	CcSEcCtD
Darifenacin—Shock—Esomeprazole—Barrett's esophagus	0.00195	0.00482	CcSEcCtD
Darifenacin—Shock—Omeprazole—Barrett's esophagus	0.00195	0.00482	CcSEcCtD
Darifenacin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00194	0.0048	CcSEcCtD
Darifenacin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00194	0.0048	CcSEcCtD
Darifenacin—Tachycardia—Esomeprazole—Barrett's esophagus	0.00193	0.00478	CcSEcCtD
Darifenacin—Tachycardia—Omeprazole—Barrett's esophagus	0.00193	0.00478	CcSEcCtD
Darifenacin—Skin disorder—Esomeprazole—Barrett's esophagus	0.00192	0.00476	CcSEcCtD
Darifenacin—Skin disorder—Omeprazole—Barrett's esophagus	0.00192	0.00476	CcSEcCtD
Darifenacin—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00191	0.00473	CcSEcCtD
Darifenacin—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00191	0.00473	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.0018	0.00446	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.0018	0.00446	CcSEcCtD
Darifenacin—Insomnia—Esomeprazole—Barrett's esophagus	0.00179	0.00443	CcSEcCtD
Darifenacin—Insomnia—Omeprazole—Barrett's esophagus	0.00179	0.00443	CcSEcCtD
Darifenacin—Dyspnoea—Omeprazole—Barrett's esophagus	0.00177	0.00437	CcSEcCtD
Darifenacin—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00177	0.00437	CcSEcCtD
Darifenacin—Somnolence—Omeprazole—Barrett's esophagus	0.00176	0.00435	CcSEcCtD
Darifenacin—Somnolence—Esomeprazole—Barrett's esophagus	0.00176	0.00435	CcSEcCtD
Darifenacin—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00174	0.00431	CcSEcCtD
Darifenacin—Dyspepsia—Omeprazole—Barrett's esophagus	0.00174	0.00431	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00171	0.00423	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00171	0.00423	CcSEcCtD
Darifenacin—Constipation—Omeprazole—Barrett's esophagus	0.00169	0.00419	CcSEcCtD
Darifenacin—Pain—Esomeprazole—Barrett's esophagus	0.00169	0.00419	CcSEcCtD
Darifenacin—Constipation—Esomeprazole—Barrett's esophagus	0.00169	0.00419	CcSEcCtD
Darifenacin—Pain—Omeprazole—Barrett's esophagus	0.00169	0.00419	CcSEcCtD
Darifenacin—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00163	0.00404	CcSEcCtD
Darifenacin—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00163	0.00404	CcSEcCtD
Darifenacin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00162	0.004	CcSEcCtD
Darifenacin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00162	0.004	CcSEcCtD
Darifenacin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00157	0.00387	CcSEcCtD
Darifenacin—Abdominal pain—Omeprazole—Barrett's esophagus	0.00157	0.00387	CcSEcCtD
Darifenacin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00146	0.00361	CcSEcCtD
Darifenacin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00146	0.00361	CcSEcCtD
Darifenacin—Asthenia—Omeprazole—Barrett's esophagus	0.00142	0.00351	CcSEcCtD
Darifenacin—Asthenia—Esomeprazole—Barrett's esophagus	0.00142	0.00351	CcSEcCtD
Darifenacin—Pruritus—Esomeprazole—Barrett's esophagus	0.0014	0.00347	CcSEcCtD
Darifenacin—Pruritus—Omeprazole—Barrett's esophagus	0.0014	0.00347	CcSEcCtD
Darifenacin—Diarrhoea—Omeprazole—Barrett's esophagus	0.00136	0.00335	CcSEcCtD
Darifenacin—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00136	0.00335	CcSEcCtD
Darifenacin—Dizziness—Omeprazole—Barrett's esophagus	0.00131	0.00324	CcSEcCtD
Darifenacin—Dizziness—Esomeprazole—Barrett's esophagus	0.00131	0.00324	CcSEcCtD
Darifenacin—Vomiting—Omeprazole—Barrett's esophagus	0.00126	0.00311	CcSEcCtD
Darifenacin—Vomiting—Esomeprazole—Barrett's esophagus	0.00126	0.00311	CcSEcCtD
Darifenacin—Rash—Omeprazole—Barrett's esophagus	0.00125	0.00309	CcSEcCtD
Darifenacin—Rash—Esomeprazole—Barrett's esophagus	0.00125	0.00309	CcSEcCtD
Darifenacin—Dermatitis—Omeprazole—Barrett's esophagus	0.00125	0.00309	CcSEcCtD
Darifenacin—Dermatitis—Esomeprazole—Barrett's esophagus	0.00125	0.00309	CcSEcCtD
Darifenacin—Headache—Omeprazole—Barrett's esophagus	0.00124	0.00307	CcSEcCtD
Darifenacin—Headache—Esomeprazole—Barrett's esophagus	0.00124	0.00307	CcSEcCtD
Darifenacin—Nausea—Omeprazole—Barrett's esophagus	0.00118	0.00291	CcSEcCtD
Darifenacin—Nausea—Esomeprazole—Barrett's esophagus	0.00118	0.00291	CcSEcCtD
Darifenacin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000661	0.03	CbGpPWpGaD
Darifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00038	0.0172	CbGpPWpGaD
Darifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00038	0.0172	CbGpPWpGaD
Darifenacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000369	0.0167	CbGpPWpGaD
Darifenacin—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000364	0.0165	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000339	0.0154	CbGpPWpGaD
Darifenacin—CHRM5—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000333	0.0151	CbGpPWpGaD
Darifenacin—CHRM4—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00032	0.0145	CbGpPWpGaD
Darifenacin—CHRM5—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000306	0.0139	CbGpPWpGaD
Darifenacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000299	0.0136	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000298	0.0135	CbGpPWpGaD
Darifenacin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000263	0.0119	CbGpPWpGaD
Darifenacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000241	0.0109	CbGpPWpGaD
Darifenacin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000238	0.0108	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000234	0.0106	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000234	0.0106	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000215	0.00977	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000215	0.00974	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000213	0.00964	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00021	0.0095	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000209	0.00947	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000198	0.00899	CbGpPWpGaD
Darifenacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000196	0.00886	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000183	0.00831	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000159	0.0072	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000158	0.00715	CbGpPWpGaD
Darifenacin—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000157	0.0071	CbGpPWpGaD
Darifenacin—CHRM4—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000151	0.00685	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000151	0.00685	CbGpPWpGaD
Darifenacin—CHRM5—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000145	0.00656	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—SST—Barrett's esophagus	0.000132	0.00599	CbGpPWpGaD
Darifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000125	0.00567	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—SST—Barrett's esophagus	0.00012	0.00544	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—SST—Barrett's esophagus	0.000115	0.00521	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000106	0.00482	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000106	0.00481	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000105	0.00476	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000104	0.00471	CbGpPWpGaD
Darifenacin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000102	0.00464	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000102	0.00462	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000102	0.0046	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000101	0.00456	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—GAST—Barrett's esophagus	9.91e-05	0.00449	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—GAST—Barrett's esophagus	9.49e-05	0.0043	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—GAST—Barrett's esophagus	9e-05	0.00408	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—GAST—Barrett's esophagus	8.61e-05	0.0039	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	8.1e-05	0.00367	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	8.07e-05	0.00366	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—SST—Barrett's esophagus	8e-05	0.00362	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	7.74e-05	0.00351	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.73e-05	0.0035	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	7.14e-05	0.00324	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—SST—Barrett's esophagus	6.79e-05	0.00308	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	6.68e-05	0.00303	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	6.66e-05	0.00302	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GAST—Barrett's esophagus	6.59e-05	0.00299	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—SST—Barrett's esophagus	6.5e-05	0.00295	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—SST—Barrett's esophagus	6.17e-05	0.00279	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.15e-05	0.00279	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	6.07e-05	0.00275	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	6.05e-05	0.00274	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGES—Barrett's esophagus	5.99e-05	0.00272	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GAST—Barrett's esophagus	5.99e-05	0.00271	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—SST—Barrett's esophagus	5.9e-05	0.00268	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.89e-05	0.00267	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GAST—Barrett's esophagus	5.31e-05	0.00241	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.15e-05	0.00233	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GAST—Barrett's esophagus	5.09e-05	0.00231	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL8—Barrett's esophagus	4.68e-05	0.00212	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	4.58e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	4.56e-05	0.00207	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	4.54e-05	0.00206	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—SST—Barrett's esophagus	4.52e-05	0.00205	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL8—Barrett's esophagus	4.48e-05	0.00203	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	4.16e-05	0.00188	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.14e-05	0.00188	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	4.14e-05	0.00188	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.13e-05	0.00187	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—SST—Barrett's esophagus	4.1e-05	0.00186	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.09e-05	0.00185	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SST—Barrett's esophagus	3.64e-05	0.00165	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	3.62e-05	0.00164	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.58e-05	0.00162	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	3.58e-05	0.00162	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	3.57e-05	0.00162	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GAST—Barrett's esophagus	3.54e-05	0.0016	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SST—Barrett's esophagus	3.49e-05	0.00158	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	3.27e-05	0.00148	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.16e-05	0.00143	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	3.15e-05	0.00143	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL8—Barrett's esophagus	3.12e-05	0.00141	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.72e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.65e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.53e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SST—Barrett's esophagus	2.46e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SST—Barrett's esophagus	2.45e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SST—Barrett's esophagus	2.42e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL8—Barrett's esophagus	2.4e-05	0.00109	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.34e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL8—Barrett's esophagus	2.3e-05	0.00104	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.96e-05	0.000887	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APC—Barrett's esophagus	1.93e-05	0.000873	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APC—Barrett's esophagus	1.85e-05	0.000836	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.78e-05	0.000808	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.78e-05	0.000806	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.78e-05	0.000805	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.76e-05	0.000798	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.62e-05	0.000734	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	1.61e-05	0.000732	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—Barrett's esophagus	1.6e-05	0.000725	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RELA—Barrett's esophagus	1.51e-05	0.000682	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—Barrett's esophagus	1.49e-05	0.000678	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RELA—Barrett's esophagus	1.44e-05	0.000653	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—Barrett's esophagus	1.42e-05	0.000643	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—Barrett's esophagus	1.36e-05	0.000616	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.3e-05	0.000589	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.3e-05	0.000587	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—Barrett's esophagus	1.28e-05	0.000581	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.28e-05	0.00058	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.18e-05	0.000533	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	1.02e-05	0.00046	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	1.01e-05	0.000459	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RELA—Barrett's esophagus	1e-05	0.000454	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	9.57e-06	0.000434	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	9.54e-06	0.000432	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—Barrett's esophagus	9.44e-06	0.000428	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.94e-06	0.000405	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—Barrett's esophagus	8.71e-06	0.000395	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—Barrett's esophagus	8.34e-06	0.000378	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	7.03e-06	0.000319	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	5.87e-06	0.000266	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	5.85e-06	0.000265	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.84e-06	0.000265	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—Barrett's esophagus	5.8e-06	0.000263	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.6e-06	0.000208	CbGpPWpGaD
